Skip to main content

News

News
09/02/2025
VARIPURE demonstrated strong safety outcomes with no incidence of stroke and 99.7% acute effectiveness of the VARIPULSE™ Platform in nearly 800 enrolled patients
VARIPURE demonstrated strong safety outcomes with no incidence of stroke and 99.7% acute effectiveness of the VARIPULSE™ Platform in nearly 800 enrolled patients
VARIPURE demonstrated strong...
09/02/2025
EP Lab Digest
News
09/02/2025
Pulmonary vein isolation (PVI) remains the cornerstone of catheter ablation for atrial fibrillation (AF) but the optimal ablation strategy has not been clarified in the persistent AF population.
Pulmonary vein isolation (PVI) remains the cornerstone of catheter ablation for atrial fibrillation (AF) but the optimal ablation strategy has not been clarified in the persistent AF population.
Pulmonary vein isolation (PVI)...
09/02/2025
EP Lab Digest
News
09/02/2025
Radiofrequency-based ablation (RFA) is a widely accepted treatment for drug-resistant atrial fibrillation; however, pulsed field ablation (PFA) may have advantages over RFA. 
Radiofrequency-based ablation (RFA) is a widely accepted treatment for drug-resistant atrial fibrillation; however, pulsed field ablation (PFA) may have advantages over RFA. 
Radiofrequency-based ablation...
09/02/2025
EP Lab Digest
Uncontrolled Hypertension
08/26/2025
Atrioventricular interval modulation (AVIM) therapy (also known as BackBeat Cardiac Neuromodulation Therapy [CNT™]) is for the treatment of hypertension. AVIM therapy is currently being evaluated in the BACKBEAT global pivotal study.
Atrioventricular interval modulation (AVIM) therapy (also known as BackBeat Cardiac Neuromodulation Therapy [CNT™]) is for the treatment of hypertension. AVIM therapy is currently being evaluated in the BACKBEAT global pivotal study.
Atrioventricular interval...
08/26/2025
EP Lab Digest